文献速递生殖医学

辅助生殖女性抑郁焦虑的注册队列研究

Depression and anxiety among women going through medically assisted reproduction: a register-based cohort study.
PubMed 文献 · Hum Reprod · 2026-01-01

丹麦全国注册队列纳入2006—2018年启动医学辅助生殖(MAR)的64 611名女性及按首次治疗日期匹配的64 611名无MAR女性,比较MAR启动前3年至后3年的抑郁与焦虑。MAR组发病率从每1000人半年19降至11、3年后升至17,呈U形;对照组稳定在约25。

要点

  • MAR女性治疗前抑郁焦虑发病率下降,治疗后回升,3年后回到治疗前水平。
  • MAR组发病率呈U形,对照组同期保持稳定。
  • 结果在精神病史、年龄、产次亚组及仅限医院诊断时一致。

核心结论

  • 启动MAR的女性在治疗前抑郁焦虑减少,启动后增加,3年后回到治疗前水平。

研究设计与样本

  • 丹麦全国注册队列研究,纳入2006—2018年启动MAR的女性64 611名,并按首次MAR治疗日期匹配无MAR对照64 611名。
  • 抑郁焦虑定义为医院诊断或抗抑郁药/抗焦虑药处方,观察MAR启动前3年至后3年。

主要发现

  • MAR组抑郁焦虑发病率在治疗前从每1000人半年19降至11,3年后升至17,呈U形。
  • 对照组发病率稳定在每1000人半年约25。
  • 按精神病史、年龄、产次分层及仅限医院诊断时结果一致。

关键数值与推荐

  • 发病率指新登记且前12个月无登记;患病率为前12个月内受诊断或处方影响的人时比例。

临床怎么用

  • 提示MAR不同阶段心理健康状况不同,可据此识别需要心理支持的重点时段。

局限性

  • 依赖登记数据,未捕捉未治疗或亚临床病例。
  • 缺乏伴侣状况、社会经济特征和生育意愿信息,两组间可能存在差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: How do the incidence and prevalence of depression and anxiety change for women during the 3 years before and after initiation of medically assisted reproduction (MAR)? SUMMARY ANSWER: Women initiating MAR experienced a decline in depression and anxiety before treatment initiation, followed by an increase after initiation, returning to pre-treatment levels 3 years later. WHAT IS KNOWN ALREADY: Infertility and its treatment are associated with psychological distress, and previous research has examined mental health trajectories shortly before, during, and after treatment. Studies suggest that emotional adjustment varies across treatment phases and outcomes, but population-based evidence on clinical depression and anxiety patterns in a longer period before treatment initiation is lacking. STUDY DESIGN, SIZE, DURATION: Nationwide register-based cohort study including all women in Denmark initiating MAR from 2006 to 2018 (n = 64 611) and a matched comparison group of women without MAR (n = 64 611), matched on the date of the first MAR treatment. Depression and anxiety were examined from 3 years before to 3 years after MAR initiation. PARTICIPANTS/MATERIALS, SETTING, METHODS: Women were identified from the Danish National Register of Assisted Reproductive Technology and matched on age, calendar year, parity, and psychiatric history. Depression and anxiety were defined as hospital diagnoses or filled prescriptions for antidepressants or anxiolytics. Incidence rates were defined as new registrations of depression or anxiety, requiring no registration in the preceding 12 months. Prevalence was defined as the proportion of person-time affected by depression or anxiety based on diagnoses or prescriptions within the preceding 12 months. MAIN RESULTS AND THE ROLE OF CHANCE: Among women undergoing MAR, the incidence rate of depression and anxiety declined from 19 to 11 per 1000 persons per half-year before treatment and rose to 17 three years after, forming a U-shaped pattern. In the comparison group, rates remained stable at about 25 per 1000 half-years. Results were consistent across subgroups defined by psychiatric history, age, and parity, and when restricting outcomes to hospital-based diagnoses. LIMITATIONS, REASONS FOR CAUTION: The study relied on registry data and did not capture untreated or subclinical cases. Information on partnership status, socioeconomic characteristics, and parenthood intentions was unavailable and may differ between groups, potentially influencing both MAR initiation and mental health outcomes. WIDER IMPLICATIONS OF THE FINDINGS: The findings suggest that women undergoing MAR experience a temporary period of improved mental health before treatment, followed by an increased risk afterwards. These descriptive patterns suggest that mental health varies across phases of fertility treatment and may help identify periods of particular relevance for mental health support in women undergoing MAR. STUDY FUNDING/COMPETING INTEREST(S): H.S. is funded by The Novo Nordisk Foundation (grant number 3110412) and The Independent Research Fund Denmark (grant number 2110290). S.E., T.M.-O., and M.B. are funded by The Novo Nordisk Foundation (grant number NNF21OC0072397). S.E. is also funded by The Psychiatric Research Fund in the Region of Southern Denmark (grant number A5752) and The Region of Southern Denmark (grant number A1784). Funding sources had no role in designing, planning, analysing, interpreting, or reviewing the manuscript. TRIAL REGISTRATION NUMBER: Not applicable.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Sonne H, Egsgaard S, Munk-Olsen T, et al. Depression and anxiety among women going through medically assisted reproduction: a register-based cohort study. Hum Reprod. 2026. PMID: 41871457. doi:10.1093/humrep/deag040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。